Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course
- 1 August 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (3) , 1106
- https://doi.org/10.1182/blood-2002-04-1287
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the diseaseBlood, 2002
- CD38 expression is an important prognostic marker in chronic lymphocytic leukaemiaLeukemia, 2002
- CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemiaBlood, 2001
- Surface CD14 positivity in B‐cell chronic lymphocytic leukaemia is related to clinical outcomeBritish Journal of Haematology, 1999
- Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic LeukemiaBlood, 1999
- Myelomonocytic antigens in B-cell chronic lymphocytic leukemiaLeukemia Research, 1995
- Myelomonocytic associated antigens in early B‐chronic lymphocytic leukemia correlate with disease activityAmerican Journal of Hematology, 1992
- Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells [letter]Blood, 1988